RARE vs CENTA

Comparison between Ultragenyx Pharmaceutical Inc (RARE, Company) and Central Garden & Pet Co. - Class A (CENTA, Company).

RARE is from the Healthcare sector, while CENTA is from the Consumer Defensive sector.

5-Year PerformanceCENTA has outperformed RARE, delivering a return of -1.9% compared to -24.9%

RARE vs CENTA - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RARE(COMPANY)	CENTA(COMPANY)
Market Cap	$2.26B	$2.26B
Max Drawdown	89.57%	85.23%
Sharpe Ratio	-0.27	0.52
5Y Beta	1.00	0.57
Industry	Biotechnology	Packaged Foods
P/E Ratio	-3.66	9.36
Forward P/E	N/A	10.86
PEG Ratio	-0.61	0.14
5Y EPS CAGR	15.22%	15.40%
Debt to Equity	0.00%	72.22%
Free Cash Flow Yield	-22.24%	12.51%
P/S Ratio	3.35	0.72
P/B Ratio	247.70	1.38

Market Cap

Winner

RARE

$2.26B

CENTA

$2.26B

Max Drawdown

RARE

89.57%

Winner

CENTA

85.23%

Sharpe Ratio

RARE

-0.27

Winner

CENTA

0.52

5Y Beta

RARE

1.00

Winner

CENTA

0.57

Industry

RARE

Biotechnology

CENTA

Packaged Foods

P/E Ratio

Winner

RARE

-3.66

CENTA

9.36

Forward P/E

RARE

N/A

CENTA

10.86

PEG Ratio

Winner

RARE

-0.61

CENTA

0.14

5Y EPS CAGR

RARE

15.22%

Winner

CENTA

15.40%

Debt to Equity

Winner

RARE

0.00%

CENTA

72.22%

Free Cash Flow Yield

RARE

-22.24%

Winner

CENTA

12.51%

P/S Ratio

RARE

3.35

Winner

CENTA

0.72

P/B Ratio

RARE

247.70

Winner

CENTA

1.38

RARE vs CENTA - Historical Returns

Returns include dividend reinvestment.

Period	RARE	CENTA
1 month	-9.28%	+9.80%
3 months	+12.16%	+18.66%
6 months	-32.79%	+24.08%
1 year	-38.02%	+20.25%
5 years(CAGR)	-24.86%	-1.91%
10 years(CAGR)	-8.63%	+9.72%
Max(CAGR)	-4.36%	+6.09%

RARE

-9.28%

Winner

CENTA

+9.80%

RARE

+12.16%

Winner

CENTA

+18.66%

RARE

-32.79%

Winner

CENTA

+24.08%

RARE

-38.02%

Winner

CENTA

+20.25%

5Y(CAGR)

RARE

-24.86%

Winner

CENTA

-1.91%

10Y(CAGR)

RARE

-8.63%

Winner

CENTA

+9.72%

Max(CAGR)

RARE

-4.36%

Winner

CENTA

+6.09%

RARE vs CENTA - Annual Returns (2007 - 2026)

Returns include dividend reinvestment.

Year	RARE	CENTA
2026	+3.18%	+30.42%
2025	-44.11%	-10.16%
2024	-12.66%	-7.50%
2023	+5.05%	+25.04%
2022	-45.11%	-25.54%
2021	-38.38%	+32.00%
2020	+221.11%	+26.76%
2019	+2.37%	-7.38%
2018	-11.79%	-16.51%
2017	-33.71%	+20.87%
2016	-30.97%	+134.45%
2015	+141.77%	+40.64%
2014	+3.86%	+44.70%
2013	N/A	-36.50%
2012	N/A	+19.79%
2011	N/A	-19.92%
2010	N/A	-0.50%
2009	N/A	+67.34%
2008	N/A	+13.24%
2007	N/A	-64.39%

RARE vs CENTA Drawdown Comparison

The maximum drawdown for RARE was -89.57%, occurring on Mar 24, 2026. This drawdown has not yet recovered.

The maximum drawdown for CENTA was -85.23%, occurring on Oct 28, 2008. Recovery took 2135 trading sessions.

The current RARE drawdown is -86.27%. The current CENTA drawdown is -13.44%.

Rank	RARE	CENTA
#1	-89.57% Dec 23, 2020 - Mar 24, 2026	-85.23% Mar 23, 2007 - Sep 15, 2015
#2	-74.79% Jul 20, 2015 - Dec 8, 2020	-50.37% Jul 6, 2018 - Feb 8, 2021
#3	-49.59% Mar 12, 2014 - Apr 22, 2015	-39.79% May 7, 2021 - Oct 13, 2025
#4	-18.98% Apr 24, 2015 - May 12, 2015	-35.17% Oct 19, 2015 - May 6, 2016
#5	-14.60% Jan 31, 2014 - Feb 12, 2014	-22.00% Apr 26, 2017 - Sep 28, 2017
#6	-8.63% Feb 21, 2014 - Mar 10, 2014	-18.14% Feb 6, 2007 - Mar 23, 2007
#7	-6.40% Dec 8, 2020 - Dec 11, 2020	-16.23% Dec 4, 2017 - Jun 11, 2018
#8	-5.97% Jun 2, 2015 - Jun 17, 2015	-13.88% Oct 6, 2016 - Nov 11, 2016
#9	-5.14% Jul 7, 2015 - Jul 9, 2015	-11.63% Oct 13, 2017 - Dec 4, 2017
#10	-5.08% Jun 23, 2015 - Jul 1, 2015	-10.74% Aug 9, 2016 - Oct 6, 2016
#11	-2.70% Feb 12, 2014 - Feb 20, 2014	-7.64% Feb 12, 2021 - Mar 5, 2021
#12	-2.65% May 21, 2015 - May 27, 2015	-7.28% Apr 5, 2021 - May 5, 2021
#13	-1.60% May 28, 2015 - Jun 2, 2015	-7.15% Feb 1, 2017 - Feb 16, 2017
#14	-1.50% Jul 14, 2015 - Jul 17, 2015	-6.83% Jan 6, 2017 - Feb 1, 2017
#15	-1.12% Jul 1, 2015 - Jul 7, 2015	-6.68% Jun 15, 2018 - Jul 3, 2018